Biologics in the treatment of primary inflammatory myositis.

[1]  B. Eymard.  Polymyosite, dermatomyosite, myosite à inclusions, aspects nosologiques , 2008 .

[2]  P. Chérin.  Traitement des myopathies inflammatoires , 2008 .

[3]  L. Espinoza,et al.  Treatment of early and refractory dermatomyositis with infliximab: a report of two cases , 2007, Clinical Rheumatology.

[4]  M. Covelli,et al.  Use of etanercept in the treatment of dermatomyositis: a case series. , 2006, The Journal of rheumatology.

[5]  L. Kagen,et al.  Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients , 2006, Annals of the rheumatic diseases.

[6]  M. Weinblatt,et al.  Rituximab as therapy for refractory polymyositis and dermatomyositis. , 2006, The Journal of rheumatology.

[7]  J. Mendell,et al.  Pilot trial of etanercept in the treatment of inclusion-body myositis , 2006, Neurology.

[8]  C. Gabay,et al.  Rituximab in the treatment of antisynthetase syndrome , 2005, Annals of the rheumatic diseases.

[9]  B. Gruber,et al.  Rituximab in the treatment of refractory dermatomyositis. , 2005, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[10]  J. Muir,et al.  Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab. , 2005, Rheumatology.

[11]  O. Lambotte,et al.  Efficacy of rituximab in refractory polymyositis. , 2005, The Journal of rheumatology.

[12]  M. Kazim,et al.  Treatment of orbital myositis with adalimumab (Humira). , 2005, The Journal of rheumatology.

[13]  A. Anandacoomarasamy,et al.  Advanced refractory polymyositis responding to infliximab. , 2005, Rheumatology.

[14]  T. Levine.  Rituximab in the treatment of dermatomyositis: an open-label pilot study. , 2005, Arthritis and rheumatism.

[15]  M. Vilardell‐Tarrés,et al.  Refractory adult dermatomyositis with pneumatosis cystoides intestinalis treated with infliximab. , 2004, Rheumatology.

[16]  I. Uthman,et al.  Refractory polymyositis responding to infliximab. , 2004, Rheumatology.

[17]  F. Moosig,et al.  IL-1RA in refractory systemic lupus erythematosus , 2004, Lupus.

[18]  C. Korkmaz,et al.  Successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha. , 2004, Rheumatology.

[19]  B. V. van Engelen,et al.  Treatment of Dermatomyositis and Polymyositis with Anti-Tumor Necrosis Factor-α: Long-Term Follow-Up , 2004, European Neurology.

[20]  B. Michel,et al.  Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1. , 2004, Rheumatology.

[21]  V. Loustaud-Ratti,et al.  Refractory polymyositis responding to infliximab: extended follow-up. , 2004, Rheumatology.

[22]  J. Musial,et al.  Polymyositis associated with infliximab treatment for rheumatoid arthritis. , 2003, Rheumatology.

[23]  P. Cherin.  [The treatment of inflammatory muscle diseases]. , 2003, Presse medicale.

[24]  M. Netea,et al.  Successful Treatment of Dermatomyositis and Polymyositis with Anti-Tumor-Necrosis-Factor-Alpha: Preliminary Observations , 2003, European Neurology.

[25]  P. Caramaschi,et al.  Orbital myositis in a rheumatoid arthritis patient during etanercept treatment. , 2003, Clinical and experimental rheumatology.

[26]  E. Roddy,et al.  Non-Hodgkin's lymphoma in a patient with refractory dermatomyositis which had been treated with infliximab. , 2002, Rheumatology.

[27]  T. Horie,et al.  Elevation of Serum Soluble Tumour Necrosis Factor Receptors in Patients with Polymyositis and Dermatomyositis , 2000, Clinical Rheumatology.

[28]  T. Horie,et al.  Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis. , 2000, Internal medicine.